The role of cytogenetics in myeloma
Authors:
- 23 August 2006
- journal article
- Published by Springer Nature in Leukemia
- Vol. 20 (9) , 1484-1486
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Relationship of patient survival and chromosome anomalies detected in metaphase and/or interphase cells at diagnosis of myelomaBlood, 2005
- Prognostic and Therapeutic Significance of Myeloma Genetics and Gene Expression ProfilingJournal of Clinical Oncology, 2005
- The recurrent translocation t(14;20)(q32;q12) in multiple myeloma results in aberrant expression of MAFB: a molecular and genetic analysis of the chromosomal breakpointBritish Journal of Haematology, 2004
- Genomic abnormalities in monoclonal gammopathy of undetermined significanceBlood, 2002
- Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentationBlood, 2002
- Hypodiploidy is a major prognostic factor in multiple myelomaBlood, 2001
- Cyclin D3 at 6p21 is dysregulated by recurrent chromosomal translocations to immunoglobulin loci in multiple myelomaBlood, 2001
- Chromosome 13 abnormalities identified by FISH analysis and serum β2-microglobulin produce a powerful myeloma staging system for patients receiving high-dose therapyBlood, 2001
- Unique role of cytogenetics in the prognosis of patients with myeloma receiving high-dose therapy and autotransplants.Journal of Clinical Oncology, 1997
- MULTIPLE MYELOMA: ALMOST ALL PATIENTS ARE CYTOGENETICALLY ABNORMALBritish Journal of Haematology, 1996